Figure 4From: Combination therapy of infliximab and thalidomide for refractory entero-Behcet's disease: a case report A CDAI score <150 points is considered clinical remission in a patient with CD. After the first infusion, the patient noticed great improvement in symptoms, and his CDAI score declined dramatically from 344 to 100 points, which indicated clinical remission.Back to article page